The ameliorating effect of 1-palmitoyl-2-linoleoyl-3-acetylglycerol on scopolamine-induced memory impairment via acetylcholinesterase inhibition and LTP activation
Authors:
- 1 May 2017
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 324, 58-65
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (NRF-2015R1A2A2A01007838)
- National Research Foundation of Korea
This publication has 26 references indexed in Scilit:
- EC-18, a synthetic monoacetyldiglyceride (1-palmitoyl-2-linoleoyl-3-acetylglycerol), attenuates the asthmatic response in an aluminum hydroxide/ovalbumin-induced model of asthmaInternational Immunopharmacology, 2014
- Deer antler base as a traditional Chinese medicine: A review of its traditional uses, chemistry and pharmacologyJournal of Ethnopharmacology, 2013
- The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studiesNeuroscience & Biobehavioral Reviews, 2010
- Effect of aqueous antler extract on scopolamine-induced memory impairment in mice and antioxidant activitiesFood Science and Biotechnology, 2010
- EC-18, a Synthetic Monoacetyldiacylglyceride, Inhibits Hematogenous Metastasis of KIGB-5 Biliary Cancer Cell in Hamster ModelJournal of Korean Medical Science, 2009
- Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in miceLife Sciences, 2007
- Gomisin A improves scopolamine-induced memory impairment in miceEuropean Journal of Pharmacology, 2006
- Drug-induced amnesia: Implications for cognitive neuropsychological investigations of memory.Psychological Bulletin, 1993
- Pharmacologic modelling of Alzheimer's diseaseProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1986
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961